# Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

> clinical trial · VERIFIED · 2026-07-28

Status: COMPLETED · Sponsor: Institut Curie · Condition: Metastatic Uveal Melanoma

- Company: Institut Curie
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05282901

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.